The independent source for health policy research, polling, and news.
21 - 40 of 69 Results
Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.
The Affordable Care Act required that health insurers provide many medical screenings and prevention services at no out-of-pocket cost to health plan members. But insurers and employers may consider adding cost sharing for preventive services now that a federal court ruled the ACAs mandate is unconstitutional.
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
A federal judge in Texas the same one who tried to strike down the Affordable Care Act as unconstitutional in 2018 has ruled against some of the ACAs preventive benefits, including the requirement that employers cover medication to prevent HIV. Meanwhile, the U.S. Department of Veterans Affairs tries to make abortions slightly more available to veterans and their dependents. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Lauren Sausser, who reported and wrote the latest KHN-NPR Bill of the Month installment.
Even a decade in, the Affordable Care Acts recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
Under the Affordable Care Act, insurers cannot charge consumers for various preventive services that have been recommended by experts. But if those screenings indicate more testing is needed to determine whether something is wrong, patients may be on the hook for hundreds or even thousands of dollars for diagnostic services.
Preventive care, like screening colonoscopies, is supposed to be free of charge to patients under the Affordable Care Act. But some hospitals havent gotten the memo.
An aging population in need of regular cancer screenings has driven private equity companies, seeking profits, to invest in many gastroenterology practices and set up aggressive billing practices. Steep prices on routine tests are one consequence for patients.
Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHNs Julie Rovner to discuss these issues and more.
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the laws popular coverage requirement for preventive services.
The National Cancer Institute plans to launch a multisite study next year involving roughly 5,000 women to assess whether self-sampling at home for the human papillomavirus that causes cervical cancer is comparable to screening in a doctors office.
Companies are aggressively touting 3D mammograms, although theres no evidence they save lives.
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesnt apply to the other clinical and lab services people need.
Health was a featured player in President Donald Trumps 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHNs Julie Rovner to discuss these issues and, for extra credit, provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current Bill of the Month feature.
New research not only confirms the heart health benefits of a Mediterranean-style diet, but also tracks these benefits over the long term.
The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didnt find the same promise for over-the-counter fish oil supplements when tested in healthy people.
And new study finds no reason to get routine vitamin D tests, researchers say.
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
On April 1, Medicare launched a major initiative a diabetes prevention program for seniors and people with serious disabilities that is available in only a few cities.
An abortion drug invented decades ago is being used to treat Cushings syndrome and its bringing in tens of millions of dollars a year.
穢 2026 KFF